Rheumatoid arthritis (RA) is a chronic autoimmune disease that causes inflammation in the joints and can affect other parts of the body. Unlike ordinary wear-and-tear arthritis, RA occurs when the immune system mistakenly attacks healthy tissues, particularly the lining of the joints. For people whose rheumatoid arthritis remains active despite conventional treatments, biologic medicines can provide an important treatment option. These medications target specific components of the immune system involved in inflammation.
What Are Biologics?
Biologic disease-modifying antirheumatic drugs, commonly called biologics or biologic DMARDs, are medicines produced using living cells or biological processes.
Traditional DMARDs such as methotrexate affect immune activity more broadly. Biologics are designed to target specific immune pathways.
The primary goal is to:
- Reduce joint inflammation
- Relieve pain and stiffness
- Prevent joint damage
- Improve physical function
- Reduce disease activity
- Support long-term quality of life
Biologics do not cure rheumatoid arthritis, but they can help control the disease and prevent progression in many people.
When Are Biologics Used?
Biologics may be considered when rheumatoid arthritis remains active despite conventional DMARD treatment.
Methotrexate is commonly used as an initial conventional DMARD when appropriate. The American College of Rheumatology recommends a treat-to-target approach in which disease activity is monitored and treatment is adjusted when control is inadequate.
Biologics may be used alone in selected situations or in combination with conventional DMARDs, particularly methotrexate.
The appropriate treatment depends on the individual clinical situation.
Major Types of RA Biologics
Several biologic classes are used to treat rheumatoid arthritis.
TNF Inhibitors
Tumor necrosis factor (TNF) is an inflammatory protein involved in RA.
TNF inhibitors block this protein and reduce inflammation.
Examples include:
- Adalimumab
- Etanercept
- Infliximab
- Certolizumab pegol
- Golimumab
These medicines are administered by injection or intravenous infusion depending on the specific drug.
IL-6 Receptor Inhibitors
Interleukin-6 (IL-6) is another inflammatory signaling molecule involved in rheumatoid arthritis.
IL-6 receptor inhibitors include:
- Tocilizumab
- Sarilumab
These medicines can be particularly useful when inflammation remains active despite other treatments.
T-Cell Costimulation Modulator
Abatacept works differently from TNF and IL-6 inhibitors.
It interferes with the activation of certain T cells involved in the immune response.
Abatacept may be administered intravenously or by subcutaneous injection depending on the formulation.
B-Cell Depleting Therapy
Rituximab targets CD20-positive B cells.
It is used for selected people with rheumatoid arthritis, particularly those who have had an inadequate response to certain other treatments.
Rituximab is administered by intravenous infusion.
How Biologics Work
Different biologics target different immune pathways.
For example:
- TNF inhibitors block tumor necrosis factor
- IL-6 inhibitors interfere with IL-6 signaling
- Abatacept modifies T-cell activation
- Rituximab reduces certain B-cell populations
Although their mechanisms differ, the overall goal is to reduce the abnormal immune activity responsible for inflammation and joint damage.
Benefits of Biologic Treatment
When effective, biologics can provide several benefits.
These may include:
- Less joint swelling
- Reduced morning stiffness
- Lower pain levels
- Better mobility
- Improved ability to perform daily activities
- Reduced progression of joint damage
- Improved disease control
Some people experience substantial improvement, while others may need to switch to another medication.
How Quickly Do Biologics Work?
The response time varies by medication and individual.
Some people notice improvement within several weeks, while others may require longer.
Rheumatologists generally monitor symptoms, physical examination findings, blood tests, and validated disease-activity measures to determine whether treatment is working.
If a biologic does not provide adequate control, treatment may be adjusted.
What If the First Biologic Does Not Work?
Not every biologic works for every person.
A rheumatologist may recommend switching:
- From one TNF inhibitor to another
- From a TNF inhibitor to another biologic class
- From a biologic to a targeted synthetic DMARD
- Between different mechanisms of action
The decision depends on whether the first treatment was ineffective, stopped working, or caused unacceptable side effects.
Biologics and Methotrexate
Methotrexate is often used together with certain biologics.
Combination therapy can improve disease control and may reduce the development of anti-drug antibodies against some biologics.
However, not every biologic requires combination treatment.
For example, some medications may be used effectively without methotrexate depending on the patient's circumstances.
Biologics Versus JAK Inhibitors
JAK inhibitors are another class of targeted DMARDs used for rheumatoid arthritis.
Examples include:
- Tofacitinib
- Baricitinib
- Upadacitinib
These are oral medications, rather than biologic drugs.
The FDA has issued boxed warnings for certain JAK inhibitors concerning serious infections, cardiovascular events, cancer, and blood clots in specified populations. Treatment selection should therefore consider individual cardiovascular, cancer, and clotting risks.